(−)-P7C3-S243 Protects a Rat Model of Alzheimer’s Disease From Neuropsychiatric Deficits and Neurodegeneration Without Altering Amyloid Deposition or Reactive Glia

National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease

Bradley T. Hyman, Creighton H. Phelps, Thomas G. Beach et al. · Alzheimer s & Dementia · 2012 · 3.1K citations · Full text

National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach

Thomas J. Montine, Creighton H. Phelps, Thomas G. Beach et al. · Acta Neuropathologica · 2011 · 2.8K citations · Full text

Neurodegenerative Diseases, Alzheimer's Disease, Aging +11

Prevalence of Neuropsychiatric Symptoms in Dementia and Mild Cognitive Impairment

Constantine G. Lyketsos, Oscar L. López, Beverly N. Jones et al. · JAMA · 2002 · 2K citations

Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: Evidence that an initially deposited species is Aβ42(43)

Takeshi Iwatsubo, Asano Odaka, Nobuhiro Suzuki et al. · Neuron · 1994 · 1.7K citations

Alzheimer's Disease, Dementia, Pathology +9

Alzheimer’s disease drug-development pipeline: few candidates, frequent failures

Jeffrey L. Cummings, Travis Morstorf, Kate Zhong · Alzheimer s Research & Therapy · 2014 · 1.7K citations · Full text